Hospitalist Doctors in Milwaukee, WI Accepting Medicare

55 Hospitalist doctors found. Showing 41 - 55

Dr. Joshua Morris, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-955-0350    Fax: 414-805-0855

Dr. Jennifer L Freeto, MD Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 9000 W Wisconsin Ave, Children's Hospital Of Wisconsin, Milwaukee, WI 53226 Phone: 414-805-3666

Dr. Rudra P Ghimire, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-955-0350    Fax: 414-805-6851

Jeffrey Stein, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2323 N Lake Dr, Milwaukee, WI 53211 Phone: 414-270-4932

Miss Melissa Anita Weekes, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-0812    Fax: 414-805-0855

Ahmed Abdullah Khan, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Dept Of Internal Medicine, Milwaukee, WI 53226 Phone: 414-805-6850    Fax: 414-805-6851

Ali Imran, M.D. Hospitalist Medicare: May Accept Medicare Assignments Practice Location: 2301 N Lake Dr, Milwaukee, WI 53211 Phone: 414-585-1000

Malini Guha Majumder, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2900 W Oaklahoma Ave, Suite 315, Milwaukee, WI 53215 Phone: 414-385-2590

Dr. Jing Xu, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-0812    Fax: 414-805-0855

Dr. Stephanie A Rossi, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Froedtert & Medical College Pre-op Clinic, Milwaukee, WI 53226 Phone: 414-805-6250    Fax: 414-805-7210

Dr. Pramod Acharya, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Dept Of Internal Medicine, Milwaukee, WI 53226 Phone: 414-955-0350    Fax: 414-805-6851

Thuyanh Culver, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 840 N 87th St, Milwaukee, WI 53226 Phone: 414-805-5550    Fax: 920-451-5143

Vladyslav Dieiev, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2900 W Oklahoma Ave, Milwaukee, WI 53215 Phone: 414-649-6000

Dr. Emily Rose Mattoon, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-0812    Fax: 414-805-0855

Jacob John Jewulski, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-955-0350    Fax: 414-955-0094

News Archive

Sinovac second quarter sales increase 52.5% to $15.7 million

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today its unaudited second quarter financial results for the period ended June 30, 2011.

Heart patients experience increase in quality of life after transcatheter aortic valve replacement

Patients who undergo a transcatheter aortic valve replacement, or TAVR - a minimally-invasive surgical procedure that repairs a damaged heart valve - experienced a significant increase in their quality of life, according to a new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City.

Rosetta Genomics announces USPTO notice of allowance for Sanger hsa-miR-451

Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostic tests, announced today the receipt of a new notice of allowance from the United States Patent and Trademark Office ("USPTO") for U.S. patent application 11/418,870, including claims related to Sanger hsa-miR-451. miR-451 is used in the Company's miRview™ mets test, which accurately identifies the primary tumor site in patients with metastatic cancer and Cancer of Unknown Primary (CUP).

Novartis' Gilenya uptake to increase

A study published this week by ITG revealed that Novartis recently approved drug, Gilenya, has already taken share from market leaders in the multiple sclerosis (MS) market, and uptake is expected to increase significantly over the next year. Gilenya came onto the market in late September as the first FDA-approved oral disease-modifying MS drug, and Novartis initially faced safety concerns and monitoring requirements that deterred some physicians from adopting the new drug.

Repetitive training improves stereo processing time in young athletes

Stereo vision allows individuals to perceive depth differences in their surroundings. Important to pedestrians and drivers, for example, depth perception plays a key role in many sporting activities.

Read more Medical News

› Verified 5 days ago

• 1
• 2
• 3(current)